Preparation and characterisation of natamycin: γ-cyclodextrin inclusion complex and its evaluation in vaginal mucoadhesive formulations

Journal of Pharmaceutical Sciences

Volumn 97, Issue 10, 2008, Pages 4319-4335

  Cevher, Erdal ^a,b   Şensoy, Demet ^a   Zloh, Mire ^b   Mülazimoǧlu, Lütfiye ^c  

^a ISTANBUL UNIVERSITY   (Turkey)

^b UNIVERSITY OF LONDON   (United Kingdom)

^c MARMARA UNIVERSITY   (Turkey)

Author keywords

Bioadhesion; Candida spp.; Carbopol 934P; Hydroxypropyl methyl cellulose; Inclusion complex; Natamycin; Vaginal drug delivery; Xanthan gum; cyclodextrin

Indexed keywords

ANTIFUNGAL AGENT; CARBOMER; GAMMA CYCLODEXTRIN; GAMMA CYCLODEXTRIN NATAMYCIN; NATAMYCIN; UNCLASSIFIED DRUG; XANTHAN;

ADHESION; ARTICLE; CANDIDIASIS; COMPLEX FORMATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SOLUBILITY; EROSION; MINIMUM INHIBITORY CONCENTRATION; SUSTAINED DRUG RELEASE; TABLET FORMULATION; VAGINA MUCOSA; WATER ABSORPTION;

EID: 55749092785     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21312     Document Type: Article

References (61)

1. Cast EK, Valenta C, Leopold M, Bernkop-Schnürch A. 2002. Design and in vitro evaluation of a novel bioadhesive vaginal drug delivery system for clotrimazole. J Control Release 81:347-354.
2. Mattia A, Cerniglia C, Baines J. Safety evaluation of certain food additives and contaminants natamycin (pimaricin), Who Food Additives Series: 48.
3. Committee for veterinary medicinal products, natamycin. The European agency for the evaluation of medicinal products veterinary medicines evaluation units. EMEA/MRL/342/98-FINAL, February 1998.
4. Czeizel AE, Kazy Z, Vargha P. 2003. A case-control teratological study of vaginal natamycin treatment during pregnancy. Reprod Toxicol 17:387-391.
5. Korteweg GC, Szabo KL, Rutten AM, Hoogerheide C. 1963. Some pharmacological properties of pimaricin and possible clinical applications of this antifungal antibiotic. Antibiot Chemother 11:261-272.
6. Brik H. Natamycin. In: Florey K, editor. Analytical profiles of drug substances and excipients. Vol. 10. New York: Academic Press, Inc. 1981. pp. 513-561.
7. Koontz JL, Marcy JE. 2003. Formation of Natamycin: Cyclodextrin inclusion complexes and their characterization. J Agric Food Chem 51:7106-7110.
8. Loftsson T, Brewster ME. 1996. Pharmaceutical applications of cyclodextrins, I: Drug solubilization and stabilization. J Pharm Sci 85:1017-1025.
9. Thompson DO. 1997. Cyclodextrins-enabling excipients: Their present and future use in pharmaceuticals. Crit Rev Ther Drug Carrier Syst 14:1-104.
10. Bilensoy E, Rouf MA, Vural I, Sen M, Hincal AA. 2006. Mucoadhesive, thermosensitive, prolonged-release vaginal gel for clotrimazole: beta-cyclodextrin complex. AAPS Pharm Sci Tech 7:E38.
11. Szejtli J. 1998. Introduction and general overview of cyclodextrin chemistry. Chem Rev 98:1743-1753.
12. Martin Del Valle EM. 2004. Cyclodextrins and their uses: A review. Process Biochem 39:1033-1046.
13. Munoz de la Pena A, Ndou TT, Zung JB, Greene KL, Live DH, Warner IM. 1991. Alcohol size as a factor in the ternary complexes formed with pyrene and beta cyclodextrin. J Am Chem Soc 113:1572-1577.
14. Hirsch W, Fries V, Altman L. 1985. Effect of cyclodextrins on sparingly soluble salts. J Pharm Sci 74:1123-1125.
15. Challa R, Alka A, Javed A, Khar RK. 2005. Cyclodextrins in drug delivery: An updated review. AAPS Pharm Sci Tech 6:E329-E357.
16. Lug M, Laćan MB. 2004. Influence of hydroxypropyl-b-cyclodextrin complexation on piroxicam release from bucoadhesive tablets. Eur J Pharm Sci 21:251-260.
17. Chang JY, Oh YK, Kong HS, Kim EJ, Jang DD, Nam KT, Kim CK. 2002. Prolonged antifungal effects of clotrimazole-containing mucoadhesive thermosensitive gels on vaginitis. J Control Release 82:39-50.
18. Vermani K, Garg S. 2000. The scope and potential of vaginal drug delivery. Pharm Sci Technol Today 3:359-364.
19. Duchene D, Ponchel G. 1992. Principle and investigations of the bioadhesion mechanism of solid dosage forms. Biomaterials 13:709-714.
20. Chowdary KPR, Rao YS. 2004. Mucoadhesive microspheres for controlled drug delivery. Biol Pharm Bull 27:1717-1734.
21. Valenta C. 2005. The use of mucoadhesive polymers in vaginal drug delivery. Adv Drug Del Rev 57:1692-1712.
22. Smart JD. 1993. Drug delivery using buccal-adhesive systems. Adv Drug Del Rev 11:253-270.
23. Guggi D, Marschütz MK, Bernkop-Schnürch A. 2004. Matrix tablets based on thiolated poly(acrylic acid): pH-dependent variation in disintegration and mucoadhesion. Int J Pharm 274:97-105.
24. Miyazaki S, Kawasaki N, Nakamura T, Iwatsu M, Hayashi T, Hou WM, Attwood D. 2000. Oral mucosal bioadhesive tablets of pectin and HPMC: In vitro and in vivo evaluation. Int J Pharm 204:127-132.
25. Jug M, Bećirević-Laćan M. 2004. Influence of hydroxypropyl-bcyclodextrin complaxation piroxicam release from buccoadhesive tablets. Eur J Pharm Sci 21:251-260.
26. Higuchi T, Connors KA. 1965. Phase-solubility techniques. Adv Anal Chem Instr 4:117-212.
27. Koontz JL, Marcy JE, Barbeau WE, Duncan SE. 2003. Stability of Natamycin and its cyclodextrin inclusion complexes in aqueous solution. J Agric Food Chem 51:7111-7114.
28. Jeener J, Meier BH, Ernst BP, Ernst RR. 1979. Investigation of exchange processes by two-dimensional NMR spectroscopy. J Chem Phys 71:4546-4553.
29. Mohamadi F, Richards N, Guida W, Liskamp R, Lipton M, Caulfield C, Chang G, Hendrickson T, Still W. 1990. MacroModel - An integrated software system for modeling organic and bioorganic molecules using molecular mechanics. J Comput Chem 11:440-467.
30. Cramer CJ, Truhlar DG. Continuum solution model: classical and quantum mechanical implementations. In: Lipkowitz KB, Boyd DB, editors. Reviews in computational chemistry. Vol. 6. New York: VCH. 1995. pp. 1-72.
31. Still WC, Tempczyk A, Hawley RC, Hendrickson T. 1990. Semianalytical treatment of solvation for molecular mechanics and dynamics. J Am Chem Soc 112:6127-6129.
32. Shenkin PS, McDonald DQ. 1994. Cluster analysis of molecular conformations. J Comput Chem 15:899-916.
33. National Committee for Clinical Laboratory Standards. 1997. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved Standard. Document M27-A. National Committee for Clinical Laboratory Standards, Wayne, PA.
34. USP28/NF23. 2005. United States Pharmacopeia 28/National Formulary. 23. Pharmaceutical Convention Inc. Rockwell, MD, USA.
35. Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. 1983. Mechanisms of potassium chloride release from compressed, hydrophilic, polymeric matrices: Effect of entrapped air. J Pharm Sci 72:1189-1191.
36. Peppas NA. 1985. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv 60:110-111.
37. Ritger PL, Peppas NA. 1987. A simple equation for descriction of solute release. II Fickian and anomalous release from swellable devices. J Control Release 5:37-42.
38. Ahmed MO, El-Gibaly I, Ahmed SM. 1998. Effect of cyclodextrins on the physicochemical properties and antimycotic properties of clotrimazole. Int J Pharm 171:111-121.
39. Loftsson T, Magnusdottir A, Masson M, Sigurjonsdottir JF. 2002. Self-association and cyclodextin solubilization of drugs. J Pharm Sci 91:2307-2316.
40. Anselmi C, Centini M, Ricci M, Buonocore A, Granata P, Tsuno T, Facino RM. 2006. Analytical characterization of a ferulic acid/gamma-cyclodextrin inclusion complex. J Pharm Biomed Anal 40:875-881.
41. Pralhad T, Rajendrakumar K. 2004. Study of freeze-dried quercetin-cyclodextrin binary systems by DSC, FT-IR, X-ray diffraction and SEM analysis. J Pharm Biomed Anal 34:333-339.
42. Jambhekar S, Casella R, Maher T. 2004. The physicochemical characteristics and bioavailability of indomethacin from beta-cyclodextrin, hydroxyethyl-beta-cyclodextrin, and hydroxypropyl-beta-cyclodextrin complexes. Int J Pharm 270:149-166.
43. Reddy MN, Rehana T, Ramakrishna S, Chowdhary KPR, Diwan PV. 2004. Beta-cyclodextrin complexes of celecoxib: Molecular-modeling, characterization, and dissolution studies. AAPS Pharm Sci Tech 5-6:E7.
44. Singla AK, Garg A, Aggarwal D. 2002. Paclitaxel and its formulations. Int J Pharm 235:179-192.
45. Brik H. 1976. New high-molecular decomposition products of natamycin (pimaricin) with intact lactone-ring. J Antibiot 29:632-637.
46. Tansho S, Abe S, Ishibashi H, Torii S, Otani H, Ono Y, Yamaguchi H. 2006. Efficacy of intravenous itraconazole against invasive pulmonary aspergillosis in neutropenic mice. J Infect Chemother 12:355-362.
47. Hamada H, Ishihara K, Masuoka N, Mikuni K, Nakajima N. 2006. Enhancement of water-solubility and bioactivity of paclitaxel using modified cyclodextrins. J Biosci Bioeng 102:369-371.
48. Tur KM, Ching HS. 1998. Evaluation of possible mechanism(s) of bioadhesion. Int J Pharm 160:61-74.
49. Fabregas JL, Garcia N. 1995. In-vitro studies on bucoadhesive tablet formulations of hydrocortisone hemisuccinate. Drug Dev Ind Pharm 21:1689-1696.
50. Peppas NA, Bury PA. 1985. Surface interfacial and molecular aspects of polymer bioadhesion on soft tissues. J Control Release 2:257-275.
51. Baloglu E, Ozyazici M, Hizarcioglu SY, Karavana HA. 2003. An in vitro investigation for vaginal bioadhesive formulations: Bioadhesive properties and swelling states of polymer mixtures. Farmaco 58:391-396.
52. Nafee NA, Ismail FA, Boraie NA, Mortada LM. 2004. Mucoadhesive delivery systems. I. Evaluation of mucoadhesive polymers for buccal tablet formulation. Drug Dev Ind Pharm 30:985-993.
53. Sharma G, Jain S, Tiwary AK, Kaur G. 2006. Once daily bioadhesive vaginal clotrimazole tablet: Design and evaluation. Acta Pharm 56:337-345.
54. Noveon Pharmaceutical Bulletin 16: Bioadhesion, Noveon Inc., Cleveland, Ohio.
55. Mortazavi SA, Smart JD. 1994. Factors influencing gel strengthening at the mucoadhesive-mucus interface. J Pharm Pharmacol 48:285-287.
56. Ranga Rao KV, Buri P. 1989. A novel in situ method to test polymers and coated microparticles for bioadhesion. Int J Pharm 52:265-270.
57. Cevher E, Taha MAM, Orlu M, Araman A. 2008. Evaluation of mechanical and mucoadhesive properties of clomiphene citrate gel formulations containing carbomers and their thiolated derivatives. Drug Deliv 15:57-67.
58. Ceschel GC, Maffei P, Lombardi Borgia S, Ronchi C, Rossi S. 2001. Development of a mucoadhesive dosage form for vaginal administration. Drug Dev Ind Pharm 27:541-547.
59. Khamanga SM, Walker RB. 2006. Evaluation of rate of swelling and erosion of verapamil (VRP) sustained-release matrix tablets. Drug Dev Ind Pharm 32:1139-1148.
60. Fassihi RA, Ritschel WA. 1993. Multiple layer, direct compresiion controlled release systems: In vitro and in vivo evaluation. J Pharm Sci 82:750-754.
61. Baloglu E, Ozyazici M, Hizarcioglu SY, Şenyigit T, Özyurt D, Pekcetin C. 2006. Bioadhesive controlled release systems of ornidazole for vaginal delivery. Pharm Dev Tech 11:477-484.